These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 810794)

  • 21. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis.
    Campos-Neto A; Ovendale P; Bement T; Koppi TA; Fanslow WC; Rossi MA; Alderson MR
    J Immunol; 1998 Mar; 160(5):2037-41. PubMed ID: 9498737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacteriophages. Their role in tuberculosis and sarcoidosis.
    MANKIEWICZ E; VAN WALBEEK M
    Arch Environ Health; 1962 Aug; 5():122-8. PubMed ID: 14469306
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of age on immunity to infection with Mycobacterium tuberculosis.
    Vesosky B; Turner J
    Immunol Rev; 2005 Jun; 205():229-43. PubMed ID: 15882357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "The very pulse of the machine": the tuberculous granuloma in motion.
    Davis JM; Ramakrishnan L
    Immunity; 2008 Feb; 28(2):146-8. PubMed ID: 18275827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined application of mycobacteriophages and tubazid in experimental tuberculosis].
    Sharov GI; Gel'berg SI; Peschanskiĭ VS
    Probl Tuberk; 1974; (12):67-71. PubMed ID: 4445140
    [No Abstract]   [Full Text] [Related]  

  • 27. [Level and spectrum of tuberculosis antibodies in mice sensitive and resistant to tuberculosis].
    Litvinov VI; Markov AN; Nikonenko BV; Chernousova LN; Dem'ianenko NV; Safonova SG
    Probl Tuberk; 1993; (2):53-5. PubMed ID: 7984575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA; Hernández-Pando R; Zumla A
    J Infect Dis; 2009 Mar; 199(5):613-8. PubMed ID: 19199549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity and pathogenesis of tuberculosis.
    Ortona L; Cauda R
    Rays; 1998; 23(1):55-63. PubMed ID: 9673135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody responses against Mycobacterium tuberculosis and production of monoclonal antibodies in mice.
    Ljungqvist L; Worsaae A; Heron I
    Acta Leprol; 1989; 7 Suppl 1():184-5. PubMed ID: 2503986
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].
    Zemskova ZS; Dorozhkova IR
    Probl Tuberk; 1991; (11):63-6. PubMed ID: 1775467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis immune reconstitution inflammatory syndrome: drug resistance and the critical need for better diagnostics.
    Friedland G
    Clin Infect Dis; 2009 Mar; 48(5):677-9. PubMed ID: 19191656
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of tuberculosis by tumor necrosis factor neutralization.
    Jacobs M; Samarina A; Grivennikov S; Botha T; Allie N; Fremond C; Togbe D; Vasseur V; Rose S; Erard F; Monteiro A; Quesniaux V; Ryffel B
    Eur Cytokine Netw; 2007 Mar; 18(1):5-13. PubMed ID: 17400533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of mycobacteriophage to intracellular mycobacteria in vitro.
    Peng L; Chen BW; Luo YA; Wang GZ
    Chin Med J (Engl); 2006 Apr; 119(8):692-5. PubMed ID: 16635416
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advance in DNA vaccine against Mycobacterium tuberculosis].
    Wang BL; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.